T Cell Activation and Clonal Selection
Cell-mediated Immune Responses
Abnormal Proliferation
Cytotoxic T Cells-mediated Immune Response
T Cell Types and Functions
Receptor Downregulation in MVBs
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 19, 2025

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
Published on: August 1, 2025
Barbara Maier1,2,3, Andrew M Leader1,2,3, Steven T Chen1,2,3
1The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
This paper has been amended. Please refer to the link at the top of the document for the updated version, ensuring you access the latest research findings.
10:13Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
11:48Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
Area of Science:
Context:
Purpose:
Summary:
Impact: